Exponent Announces Successful Completion of Fifth Fundraising Round
Funding | Jul 16, 2025 | Rede Partners
Exponent, a well-regarded European mid-market private equity firm, has finalized the closure of its fifth fund, Exponent Private Equity Partners V, raising an impressive €900 million in commitments which translates into over €1 billion - surpassing their target by 20%. The fund garnered support from a diversified mix of global investors, encompassing entities in North America, Europe, the Middle East, and Asia, including pension funds, endowments, sovereign wealth funds, and family offices. Fund V is committed to continuing Exponent's strategy of investing in high-echelon mid-market companies, focusing on corporate, family, and founder-owned businesses. Exponent's historical control as the primary private equity owner reflects its modus operandi of doubling profits via revenue growth. Fund V has already completed four investments: Chanelle Pharma, Ethos Engineering, Kingsbridge Healthcare Group, and Hippo Digital, each aligning with Exponent's investment philosophy.
Sectors
- Private Equity
- Healthcare
- Technology & Digital Transformation
- Pharmaceuticals
- Engineering & Sustainable Design
Geography
- Europe – Exponent is a European PE firm, and its investments in companies like Chanelle Pharma and Ethos Engineering are European-based.
- North America, Middle East, Asia – These regions are homes to some of the investors participating in Exponent’s Fund V.
- Ireland – Kingsbridge Healthcare Group operates mainly within Northern Ireland and the Republic of Ireland.
Industry
- Private Equity – The article discusses Exponent’s Private Equity Fund, showcasing fundraising activities and investment strategies.
- Healthcare – Includes investment in Kingsbridge Healthcare Group, influencing private healthcare operations in Ireland.
- Technology & Digital Transformation – Covers investment in Hippo Digital, emphasizing user-centred digital transformation in technology consultancy.
- Pharmaceuticals – Includes Chanelle Pharma, a prominent entity in generic and veterinary pharmaceuticals in Europe.
- Engineering & Sustainable Design – Pertains to investment in Ethos Engineering, specializing in sustainable data centre designs.
Financials
- €900 million – The amount in commitments raised by Exponent's Fund V, over €1 billion, exceeding the initial fundraising target by 20%.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Exponent Private Equity | Fund Manager | Company | A European mid-market private equity firm managing the Exponent Private Equity Partners V. |
| Rede Partners | Advisor | Company | Advised Exponent on the fundraising of Fund V. |
| Chanelle Pharma | Portfolio Company | Company | A European leader in generic and veterinary pharmaceuticals. |
| Ethos Engineering | Portfolio Company | Company | A specialist in sustainable, mission-critical data centre design. |
| Kingsbridge Healthcare Group | Portfolio Company | Company | The largest private healthcare provider in Northern Ireland. |
| Hippo Digital | Portfolio Company | Company | A technology consultancy focused on user-centred digital transformation. |